NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 50 filers reported holding NUVALENT INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,786,839 | +8.3% | 60,623 | -0.7% | 0.00% | 0.0% |
| Q2 2023 | $2,573,297 | +174124.6% | 61,022 | +7.8% | 0.00% | 0.0% |
| Q1 2023 | $1,477 | -17.9% | 56,620 | -6.3% | 0.00% | 0.0% |
| Q4 2022 | $1,800 | -99.8% | 60,447 | +61.4% | 0.00% | – |
| Q3 2022 | $728,000 | +29.3% | 37,452 | -9.7% | 0.00% | – |
| Q2 2022 | $563,000 | +76.5% | 41,491 | +56.4% | 0.00% | – |
| Q1 2022 | $319,000 | +2.6% | 26,526 | +68.4% | 0.00% | – |
| Q4 2021 | $311,000 | -12.4% | 15,749 | 0.0% | 0.00% | – |
| Q3 2021 | $355,000 | – | 15,749 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,341,024 | $436,140,000 | 8.51% |
| Fairmount Funds Management LLC | 914,614 | $20,625,000 | 7.50% |
| Bain Capital Life Sciences Investors, LLC | 3,428,014 | $77,302,000 | 4.80% |
| VR Adviser, LLC | 803,951 | $18,129,000 | 2.33% |
| Boxer Capital, LLC | 1,210,192 | $27,290,000 | 0.95% |
| BVF INC/IL | 448,512 | $10,114,000 | 0.40% |
| Avoro Capital Advisors LLC | 1,257,671 | $22,288,000 | 0.35% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,052,394 | $23,731,000 | 0.28% |
| Perceptive Advisors | 750,000 | $16,913,000 | 0.25% |
| Logos Global Management LP | 134,650 | $2,733,000 | 0.20% |